Hepatobiliary Complications in Critically Ill Patients

被引:9
作者
Cheung, Amanda [1 ]
Flamm, Steven [2 ]
机构
[1] Stanford Univ, Div Gastroenterol & Hepatol, Sch Med, 750 Welch Rd,Suite 210, Palo Alto, CA 94304 USA
[2] Northwestern Feinberg Sch Med, Div Gastroenterol & Hepatol, 19-046 Arkes Bldg,676 North St Clair, Chicago, IL 60611 USA
关键词
Critical illness; Hepatobiliary; Acute liver injury; Acute liver failure; Hypoxic liver injury; Cholestatic liver injury; INTENSIVE-CARE-UNIT; HYPOXIC HEPATITIS; HEART-FAILURE; SCLEROSING CHOLANGITIS; HOSPITAL MORTALITY; ISCHEMIC HEPATITIS; CRITICAL ILLNESS; ORGAN FAILURE; LIVER-INJURY; BILE-ACIDS;
D O I
10.1016/j.cld.2018.12.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Critically ill patients frequently present with the systemic inflammatory response syndrome, which is largely a reflection of the liver's response to injury. Underlying hepatic congestion is a major risk factor for hypoxic liver injury, the most common cause for hepatocellular injury. Cholestatic liver injury often occurs in critically ill patients due to inhibition of farnesoid X receptor (FXR), the main regulator of bile acid handling, particularly in the liver and intestines. Additional injury to the liver occurs due to alterations in the bile acid pool with increased cytotoxic forms and disturbance in the typical processing of xenobiotics in the liver.
引用
收藏
页码:221 / +
页数:13
相关论文
共 54 条
[1]   Understanding gastrointestinal perfusion in critical care: so near, and yet so far [J].
Ackland, G ;
Grocott, MPW ;
Mythen, MG .
CRITICAL CARE, 2000, 4 (05) :269-281
[2]   Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program [J].
Allen, Larry A. ;
Felker, G. Michael ;
Pocock, Stuart ;
McMurray, John J. V. ;
Pfeffer, Marc A. ;
Swedberg, Karl ;
Wang, Duolao ;
Yusuf, Salim ;
Michelson, Eric L. ;
Granger, Christopher B. .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (02) :170-177
[3]  
[Anonymous], NAT REV GASTRO HEPAT
[4]   Review article: drug-induced liver injury - its pathophysiology and evolving diagnostic tools [J].
Au, J. S. ;
Navarro, V. J. ;
Rossi, S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (01) :11-20
[5]   Acute Liver Failure [J].
Bernal, William ;
Wendon, Julia .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (26) :2525-2534
[6]   Hypoxic hepatopathy: Pathophysiology and prognosis [J].
Birrer, Richard ;
Takuda, Yasuharu ;
Takara, Tsuyoshi .
INTERNAL MEDICINE, 2007, 46 (14) :1063-1070
[7]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[8]   Jaundice in critical illness: promoting factors of a concealed reality [J].
Brienza, N ;
Dalfino, L ;
Cinnella, G ;
Diele, C ;
Bruno, F ;
Fiore, T .
INTENSIVE CARE MEDICINE, 2006, 32 (02) :267-274
[9]   SERUM LACTIC-DEHYDROGENASE IN THE DIFFERENTIAL-DIAGNOSIS OF ACUTE HEPATOCELLULAR INJURY [J].
CASSIDY, WM ;
REYNOLDS, TB .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1994, 19 (02) :118-121
[10]   Alcohol Metabolism [J].
Cederbaum, Arthur I. .
CLINICS IN LIVER DISEASE, 2012, 16 (04) :667-+